Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

New York Times - Sep 30, 2026

Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.

Read full article

MORE NEWS

Science Thread

Science Thread delivers quality and fascinating science and technology content that matters on a daily basis and makes it go viral.

Sign Up